White-Coat Effect Among Older Adults: Data From the Jackson Heart Study

J Clin Hypertens (Greenwich). 2016 Feb;18(2):139-45. doi: 10.1111/jch.12644. Epub 2015 Aug 17.

Abstract

Many adults with elevated clinic blood pressure (BP) have lower BP when measured outside the clinic. This phenomenon, the "white-coat effect," may be larger among older adults, a population more susceptible to the adverse effects of low BP. The authors analyzed data from 257 participants in the Jackson Heart Study with elevated clinic BP (systolic/diastolic BP [SBP/DBP] ≥140/90 mm Hg) who underwent ambulatory BP monitoring (ABPM). The white-coat effect for SBP was larger for participants 60 years and older vs those younger than 60 years in the overall population (12.2 mm Hg, 95% confidence interval [CI], 9.2-15.1 mm Hg and 8.4 mm Hg, 95% CI, 5.7-11.1, respectively; P=.06) and among those without diabetes or chronic kidney disease (15.2 mm Hg, 95% CI, 10.1-20.2 and 8.6 mm Hg, 95% CI, 5.0-12.3, respectively; P=.04). After multivariable adjustment, clinic SBP ≥150 mm Hg vs <150 mm Hg was associated with a larger white-coat effect. Studies are needed to investigate the role of ABPM in guiding the initiation and titration of antihypertensive treatment, especially among older adults.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Black or African American / psychology
  • Black or African American / statistics & numerical data
  • Blood Pressure Monitoring, Ambulatory* / methods
  • Blood Pressure Monitoring, Ambulatory* / psychology
  • Comorbidity
  • Demography
  • Disease Management
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mississippi / epidemiology
  • Outcome Assessment, Health Care
  • Risk Factors
  • Socioeconomic Factors
  • White Coat Hypertension* / diagnosis
  • White Coat Hypertension* / ethnology
  • White Coat Hypertension* / psychology
  • White Coat Hypertension* / therapy